Phenethylsulfone isoindoline derivatives and their use
申请人:Kumar Gondi
公开号:US08853175B2
公开(公告)日:2014-10-07
Provided are phenethyl isoindoline compounds, and pharmaceutically acceptable salts, solvates, or stereoisomers thereof. Methods of use and pharmaceutical compositions of these compounds are also disclosed.
PHENETHYLSULFONE ISOINDOLINE DERIVATIVES AS INHIBITORS OF PDE 4 AND/OR CYTOKINES
申请人:Celgene Corporation
公开号:EP2663549A1
公开(公告)日:2013-11-20
US8853175B2
申请人:——
公开号:US8853175B2
公开(公告)日:2014-10-07
[EN] PHENETHYLSULFONE ISOINDOLINE DERIVATIVES AS INHIBITORS OF PDE 4 AND/OR CYTOKINES<br/>[FR] DÉRIVÉS D'ISOINDOLINE PHÉNÉTYLSULFONE COMME INHIBITEURS DE PDE 4 ET/OU DE CYTOKINES
申请人:CELGENE CORP
公开号:WO2012096884A1
公开(公告)日:2012-07-19
Provided are phenethyl isoindoline compounds, and pharmaceutically acceptable salts, solvates, or stereoisomers thereof. Methods of use and pharmaceutical compositions of these compounds are also disclosed.
PHENETHYLSULFONE ISOINDOLINE DERIVATIVES AND THEIR USE
申请人:KUMAR Gondi
公开号:US20120178708A1
公开(公告)日:2012-07-12
Provided are phenethyl isoindoline compounds, and pharmaceutically acceptable salts, solvates, or stereoisomers thereof. Methods of use and pharmaceutical compositions of these compounds are also disclosed.